Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer’s disease pathologies
Open accessAbstract
Netrin-1 reduction activates AEP that cleaves UNC5C receptor, contributing to AD pathogenesis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
δ-Secretase precuts APP, facilitating β-secretase 1 access, and simultaneously cleaves TrkB, tau, and UNC5C, amplifying both Aβ production and tau pathology.
“For example, δ-Secretase precuts APP, facilitating β-secretase 1 access, and simultaneously cleaves proteins such as tropomyosin receptor kinase B (TrkB), tau, and netrin receptor (UNC5C), amplifying both Aβ production and tau pathology [32].”
From Toward a Unified Framework in Molecular Neurobiology of Alzheimer’s Disease: Revisiting the Pathophysiological Hypotheses (2026) · cites this paper as [32]
The Introduction and Results report that δ-secretase cleaves APP, tau, and UNC5C, with increased Aβ production and tau-related pathology. The Results identify APP cleavage at N585, but do not say that this gives β-secretase 1 access. The Discussion says cleaved tau binds TrkB and inhibits its signaling; it does not say δ-secretase cleaves TrkB. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
Bai, B., Wang, X., Li, Y., Chen, P.-C., Yu, K., Dey, K. K., Yarbro, J. M., Han, X., Lutz, B. M., Rao, S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.015 · Cited by 632 · cited 1× · see citing works
“Nevertheless, recent proteomic analysis showed that netrin-1 is elevated in AD brains ( 41 ), which is contradictory to what we have found in the AD brains (Fig.”
ResultXiang, J., Wang, Z.-H., Ahn, E. H., Liu, X., Yu, S.-P., Manfredsson, F. P., Sandoval, I. M., Ju, G., Wu, S., & Ye, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901348116 · Cited by 67 · see citing works
Self-citationSpilman, P. R., Corset, V., Gorostiza, O., Poksay, K. S., Galvan, V., Zhang, J., Rao, R., Peters-Libeu, C., Vincelette, J., McGeehan, A., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151046 · Cited by 39 · see citing works
Flagged first, then by citations
Research works printed but not linked: 40
- [1]D. M. Holtzman, J. C. Morris, A. M. Goate, Alzheimer’s disease: The challenge of the second century. Sci. Transl. Med. 3, 77sr71 (2011). PMC3130546 21471435
- [2]S. W. Moore, M. Tessier-Lavigne, T. E. Kennedy, Netrins and their receptors. Adv. Exp. Med. Biol. 621, 17– 31 (2007). 18269208
- [3]K. Hong, L. Hinck, M. Nishiyama, M. M. Poo, M. Tessier-Lavigne, E. Stein, A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell 97, 927– 941 (1999). 10399920
- [4]D. Bradford, S. J. Cole, H. M. Cooper, Netrin-1: Diversity in development. Int. J. Biochem. Cell Biol. 41, 487– 493 (2009). 18455953
- [5]M. Shabani, M. Haghani, P. E. Tazangi, M. Bayat, S. M. Shid Moosavi, H. Ranjbar, Netrin-1 improves the amyloid-β-mediated suppression of memory and synaptic plasticity. Brain Res. Bull. 131, 107– 116 (2017). 28389207
- [6]E. Zamani, M. Parviz, M. Roghani, P. Mohseni-Moghaddam, Key mechanisms underlying netrin-1 prevention of impaired spatial and object memory in Aβ1-42 CA1-injected rats. Clin. Exp. Pharmacol. Physiol. 46, 86– 93 (2019). 30066400
- [7]L. Sun, T. Ju, T. Wang, L. Zhang, F. Ding, Y. Zhang, R. An, Y. Sun, Y. Li, Y. Lu, X. Zhang, L. Chi, Decreased netrin-1 and correlated Th17/Tregs balance disorder in Aβ1–42 induced Alzheimer’s disease model rats. Front. Aging Neurosci. 11, 124 (2019). 31191297 PMC6548067
- [8]F. C. Lourenço, V. Galvan, J. Fombonne, V. Corset, F. Llambi, U. Müller, D. E. Bredesen, P. Mehlen, Netrin-1 interacts with amyloid precursor protein and regulates amyloid-β production. Cell Death Differ. 16, 655– 663 (2009). 19148186 PMC2757418
- [9]N. Rama, D. Goldschneider, V. Corset, J. Lambert, L. Pays, P. Mehlen, Amyloid precursor protein regulates netrin-1-mediated commissural axon outgrowth. J. Biol. Chem. 287, 30014– 30023 (2012). 22782894 PMC3436182
- [10]P. G. Ridge, K. B. Hoyt, K. Boehme, S. Mukherjee, P. K. Crane, J. L. Haines, R. Mayeux, L. A. Farrer, M. A. Pericak-Vance, G. D. Schellenberg, J. S. K. Kauwe; Alzheimer’s Disease Genetics Consortium (ADGC), Assessment of the genetic variance of late-onset Alzheimer’s disease. Neurobiol. Aging 41, 200.e13– 200.e20 (2016). PMC4948179 27036079
- [11]M. K. Wetzel-Smith, J. Hunkapiller, T. R. Bhangale, K. Srinivasan, J. A. Maloney, J. K. Atwal, S. M. Sa, M. B. Yaylaoglu, O. Foreman, W. Ortmann, N. Rathore, D. V. Hansen, M. Tessier-Lavigne; Alzheimer’s Disease Genetics Consortium, R. Mayeux, M. Pericak-Vance, J. Haines, L. A. Farrer, G. D. Schellenberg, A. Goate, T. W. Behrens, C. Cruchaga, R. J. Watts, R. R. Graham, A rare mutation in UNC5C predisposes to late-onset Alzheimer’s disease and increases neuronal cell death. Nat. Med. 20, 1452– 1457 (2014). 25419706 PMC4301587
- [12]Y. Hashimoto, Y. Toyama, S. Kusakari, M. Nawa, M. Matsuoka, An Alzheimer disease-linked rare mutation potentiates netrin receptor uncoordinated-5C-induced signaling that merges with amyloid β precursor protein signaling. J. Biol. Chem. 291, 12282– 12293 (2016). 27068745 PMC4933276
- [13]J.-H. Sun, H.-F. Wang, X.-C. Zhu, W.-J. Yu, C.-C. Tan, T. Jiang, M.-S. Tan, L. Tan, J.-T. Yu; Alzheimer’s Disease Neuroimaging Initiative, The impact of UNC5C genetic variations on neuroimaging in Alzheimer’s disease. Mol. Neurobiol. 53, 6759– 6767 (2016). 26660111
- [14]H.-S. Yang, C. C. White, L. B. Chibnik, H.-U. Klein, J. A. Schneider, D. A. Bennett, P. L. De Jager, UNC5C variants are associated with cerebral amyloid angiopathy. Neurol. Genet. 3, e176 (2017). 28761931 PMC5515600
- [15]D. N. Li, S. P. Matthews, A. N. Antoniou, D. Mazzeo, C. Watts, Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278, 38980– 38990 (2003). 12860980
- [16]L. Zhao, T. Hua, C. Crowley, H. Ru, X. Ni, N. Shaw, L. Jiao, W. Ding, L. Qu, L.-W. Hung, W. Huang, L. Liu, K. Ye, S. Ouyang, G. Cheng, Z.-J. Liu, Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage. Cell Res. 24, 344– 358 (2014). 24407422 PMC3945893
- [17]Z. Liu, S.-W. Jang, X. Liu, D. Cheng, J. Peng, M. Yepes, X.-j. Li, S. Matthews, C. Watts, M. Asano, I. Hara-Nishimura, H. R. Luo, K. Ye, Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol. Cell 29, 665– 678 (2008). 18374643 PMC2819101
- [18]G. Basurto-Islas, J.-H. Gu, Y. C. Tung, F. Liu, K. Iqbal, Mechanism of tau hyperphosphorylation involving lysosomal enzyme asparagine endopeptidase in a mouse model of brain ischemia. J. Alzheimers Dis. 63, 821– 833 (2018). 29689717
- [19]Z. Zhang, M. Song, X. Liu, S. S. Kang, I.-S. Kwon, D. M. Duong, N. T. Seyfried, W. T. Hu, Z. Liu, J.-Z. Wang, L. Cheng, Y. E. Sun, S. P. Yu, A. I. Levey, K. Ye, Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease. Nat. Med. 20, 1254– 1262 (2014). 25326800 PMC4224595
- [20]Z. Zhang, M. Song, X. Liu, S. S. Kang, D. M. Duong, N. T. Seyfried, X. Cao, L. Cheng, Y. E. Sun, S. P. Yu, J. Jia, A. I. Levey, K. Ye, Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat. Commun. 6, 8762 (2015). 26549211 PMC4659940
- [21]A. Leuzy, C. Cicognola, K. Chiotis, L. Saint-Aubert, L. Lemoine, N. Andreasen, H. Zetterberg, K. Ye, K. Blennow, K. Höglund, A. Nordberg, Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease. Eur. J. Nucl. Med. Mol. Imaging 46, 1152– 1163 (2019). 30610252 PMC6451715
- [22]A. Paradisi, C. Maisse, M.-M. Coissieux, N. Gadot, F. Lépinasse, C. Delloye-Bourgeois, J.-G. Delcros, M. Svrcek, C. Neufert, J.-F. Fléjou, J.-Y. Scoazec, P. Mehlen, Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc. Natl. Acad. Sci. U.S.A. 106, 17146– 17151 (2009). 19721007 PMC2761333
- [23]P. Mehlen, C. Guenebeaud, Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr. Opin. Oncol. 22, 46– 54 (2010). 19934758
- [24]P. Mehlen, C. Furne, Netrin-1: When a neuronal guidance cue turns out to be a regulator of tumorigenesis. Cell. Mol. Life Sci. 62, 2599– 2616 (2005). 16158190 PMC11139161
- [25]P. Mehlen, S. Rabizadeh, S. J. Snipas, N. Assa-Munt, G. S. Salvesen, D. E. Bredesen, The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395, 801– 804 (1998). 9796814
- [26]F. Llambi, F. Causeret, E. Bloch-Gallego, P. Mehlen, Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 20, 2715– 2722 (2001). 11387206 PMC125255
- [27]E. Dall, H. Brandstetter, Structure and function of legumain in health and disease. Biochimie 122, 126– 150 (2016). 26403494
- [28]O. del Pozo, E. Lam, Caspases and programmed cell death in the hypersensitive response of plants to pathogens. Curr. Biol. 8, R896– R897 (1998). 9843696
- [29]A. J. De Jong, F. A. Hoeberichts, E. T. Yakimova, E. Maximova, E. J. Woltering, Chemical-induced apoptotic cell death in tomato cells: Involvement of caspase-like proteases. Planta 211, 656– 662 (2000). 11089678
- [30]J. M. Chen, P. M. Dando, N. D. Rawlings, M. A. Brown, N. E. Young, R. A. Stevens, E. Hewitt, C. Watts, A. J. Barrett, Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272, 8090– 8098 (1997). 9065484
- [31]Z.-H. Wang, P. Liu, X. Liu, F. P. Manfredsson, I. M. Sandoval, S. P. Yu, J.-Z. Wang, K. Ye, Delta-secretase phosphorylation by srpk2 enhances its enzymatic activity, provoking pathogenesis in Alzheimer’s disease. Mol. Cell 67, 812– 825.e5 (2017). 28826672 PMC5753427
- [32]Z.-H. Wang, W. Wu, S. S. Kang, X. Liu, Z. Wu, J. Peng, S. P. Yu, F. P. Manfredsson, I. M. Sandoval, X. Liu, J.-Z. Wang, K. Ye, BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT. JCI Insight 3, e99007 (2018). PMC6141178 30135302
- [33]Z.-H. Wang, J. Xiang, X. Liu, S. P. Yu, F. P. Manfredsson, I. M. Sandoval, S. Wu, J.-Z. Wang, K. Ye, Deficiency in BDNF/TrkB neurotrophic activity stimulates δ-secretase by upregulating C/EBPβ in Alzheimer’s disease. Cell Rep. 28, 655– 669.e5 (2019). 31315045 PMC6684282
- [35]D. Kim, S. L. Ackerman, The UNC5C netrin receptor regulates dorsal guidance of mouse hindbrain axons. J. Neurosci. 31, 2167– 2179 (2011). 21307253 PMC3073835
- [36]Q. Li, B.-L. Wang, F.-R. Sun, J.-Q. Li, X.-P. Cao, L. Tan, The role of UNC5C in Alzheimer’s disease. Ann. Transl. Med. 6, 178 (2018). 29951500 PMC5994511
- [37]K. Thiébault, L. Mazelin, L. Pays, F. Llambi, M.-O. Joly, J.-Y. Scoazec, J.-C. Saurin, G. Romeo, P. Mehlen, The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc. Natl. Acad. Sci. U.S.A. 100, 4173– 4178 (2003). 12655055 PMC153067
- [38]A. Bernet, L. Mazelin, M.-M. Coissieux, N. Gadot, S. L. Ackerman, J.-Y. Scoazec, P. Mehlen, Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology 133, 1840– 1848 (2007). 17967459 PMC2211510
- [39]X. Tang, S.-W. Jang, M. Okada, C.-B. Chan, Y. Feng, Y. Liu, S.-W. Luo, Y. Hong, N. Rama, W.-C. Xiong, P. Mehlen, K. Ye, Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B. Nat. Cell Biol. 10, 698– 706 (2008). 18469807 PMC2839190
- [42]C. Delloye-Bourgeois, J. Fitamant, A. Paradisi, D. Cappellen, S. Douc-Rasy, M.-A. Raquin, D. Stupack, A. Nakagawara, R. Rousseau, V. Combaret, A. Puisieux, D. Valteau-Couanet, J. Bénard, A. Bernet, P. Mehlen, Netrin-1 acts as a survival factor for aggressive neuroblastoma. J. Exp. Med. 206, 833– 847 (2009). 19349462 PMC2715117
- [43]Z. Zhang, S. S. Kang, X. Liu, E. H. Ahn, Z. Zhang, L. He, P. M. Iuvone, D. M. Duong, N. T. Seyfried, M. J. Benskey, F. P. Manfredsson, L. Jin, Y. E. Sun, J.-Z. Wang, K. Ye, Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson’s disease. Nat. Struct. Mol. Biol. 24, 632– 642 (2017). 28671665 PMC5871868
Cited by
Sorted by citations
Wang, H., Chen, G., Ahn, E. H., Xia, Y., Kang, S. S., Liu, X., Liu, C., Han, M.-H., Chen, S., & Ye, K. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-022-00430-8 · Cited by 71 · see citing works
Self-citationHein, Z. M., Karikalan, B., Gopalakrishna, P. K., Dhevi, K., Alkatiri, A., Hussan, F., Mohd Moklas, M. A., Jagadeesan, S., Che Ramli, M. D., Che Mohd Nassir, C. M. N., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05602-0 · Cited by 43 · see citing works
C/EBPβ/AEP Signaling Drives Alzheimer’s Disease Pathogenesis
Xiong, J., Zhang, Z., & Ye, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01025-w · Cited by 37 · see citing works
Self-citation
- Authors
- Chen, G., Kang, S. S., Wang, Z., Ahn, E. H., Xia, Y., Liu, X., Sandoval, I. M., Manfredsson, F. P., Zhang, Z., & Ye, K.
- Affiliations
- Emory University (US)
- Barrow Neurological Institute (US)
- Renmin Hospital of Wuhan University (CN)
- Corresponding author
- Zhang, Zhaohui
- Ye, Keqiang
- ORCID
- Venue
- Science Advances
- Published
- 2021-04-16
- Volume
- 7
- Issue
- 16
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8051868
- OpenAlex
- W3153292507
- Cited by
- 44
- References
- 3
- Citations by year
- 2026: 1 · 2025: 13 · 2024: 9 · 2023: 12 · 2022: 5 · 2021: 4
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG051538)
- National Institute of Neurological Disorders and Stroke (P30NS055077)
- Alzheimer’s Disease Research Center, Emory University (P30 AG066511)
- National Natural Science Foundation of China (81671051)
- National Institutes of Health under Award Number (UL1TR002378)
- National Institute of Health RF1 (AG051538)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- netrin-1, UNC5C, Alzheimer's disease, neurodegeneration, neuronal apoptosis, caspase-3 activation, APP/PS1 mice, learning and memory impairment, axon guidance receptors
- MeSH terms
- Netrin Receptors, Netrin-1, Alzheimer Disease, Animals, Cell Death, Mice, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review